United States

Top 538 largest US Companies in the Biotechnology industry by Market Cap

This is the list of the largest public listed companies in the Biotechnology industry from the United States by market capitalization with links to their reference stock.

United States Biotechnology Industry Analysis
Top US Companies United States Analysis
World Top Companies World Companies Analysis

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Top Biotechnology Companies from the United States as of Jul. 01, 2024

Download Excel

Rank Company Market Cap (USD) Country Sector Industry
361 Gain Therapeutics, Inc. $30.2 M United States US Healthcare US Biotechnology
362 VYNE Therapeutics Inc. $30.1 M

(Jan. 1, 2024)

 United States US Healthcare US Biotechnology
363 Angion Biomedica Corp $30.1 M

(June 1, 2023)

 United States US Healthcare US Biotechnology
364 Moleculin Biotech, Inc. $28.1 M

(Jan. 1, 2024)

 United States US Healthcare US Biotechnology
365 Vincera Pharma, Inc. $25.2 M

(Jan. 1, 2024)

 United States US Healthcare US Biotechnology
366 Spruce Biosciences, Inc. $23.4 M United States US Healthcare US Biotechnology
367 Yumanity Therapeutics, Inc. $20.5 M

(Dec. 1, 2022)

 United States US Healthcare US Biotechnology
368 Sensei Biotherapeutics, Inc. $19.2 M

(Jan. 1, 2024)

 United States US Healthcare US Biotechnology
369 NeuroBo Pharmaceuticals, Inc. $18.8 M

(Jan. 1, 2024)

 United States US Healthcare US Biotechnology
370 Aprea Therapeutics, Inc. $18.8 M

(Jan. 1, 2024)

 United States US Healthcare US Biotechnology
371 Metacrine, Inc. $18.8 M

(Jan. 1, 2023)

 United States US Healthcare US Biotechnology
372 Cocrystal Pharma, Inc. $18.5 M

(Jan. 1, 2024)

 United States US Healthcare US Biotechnology
373 Acorda Therapeutics, Inc. $18.0 M

(Jan. 1, 2024)

 United States US Healthcare US Biotechnology
374 Cara Therapeutics, Inc. $17.7 M United States US Healthcare US Biotechnology
375 GlycoMimetics, Inc. $17.1 M United States US Healthcare US Biotechnology
376 Lyra Therapeutics, Inc. $16.6 M United States US Healthcare US Biotechnology
377 Acer Therapeutics Inc. $16.1 M

(Nov. 1, 2023)

 United States US Healthcare US Biotechnology
378 Onconova Therapeutics, Inc. $15.6 M

(Jan. 1, 2024)

 United States US Healthcare US Biotechnology
379 BioCardia, Inc. $15.3 M

(Jan. 1, 2024)

 United States US Healthcare US Biotechnology
380 Aytu BioScience, Inc. $15.2 M

(Jan. 1, 2024)

 United States US Healthcare US Biotechnology
381 Frequency Therapeutics, Inc. $14.3 M

(July 1, 2023)

 United States US Healthcare US Biotechnology
382 Aileron Therapeutics, Inc. $14.3 M

(Jan. 1, 2024)

 United States US Healthcare US Biotechnology
383 Orgenesis Inc. $13.9 M

(Jan. 1, 2024)

 United States US Healthcare US Biotechnology
384 Landos Biopharma, Inc. $13.7 M

(Jan. 1, 2024)

 United States US Healthcare US Biotechnology
385 Applied Molecular Transport Inc. $11.0 M

(Dec. 1, 2023)

 United States US Healthcare US Biotechnology
386 ABVC BioPharma, Inc. $10.6 M

(Jan. 1, 2024)

 United States US Healthcare US Biotechnology
387 Virios Therapeutics, LLC $10.4 M

(Jan. 1, 2024)

 United States US Healthcare US Biotechnology
388 Cyclerion Therapeutics, Inc. $9.1 M

(Jan. 1, 2024)

 United States US Healthcare US Biotechnology
389 Vaccinex, Inc. $9.0 M

(Jan. 1, 2024)

 United States US Healthcare US Biotechnology
390 Aravive, Inc. $8.9 M

(Jan. 1, 2024)

 United States US Healthcare US Biotechnology

Top Biotechnology Companies from the United States as of Jul. 01, 2024

361. Gain Therapeutics, Inc.

Company Profile: Gain Therapeutics, Inc.
Market Cap (USD): $30.2 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

362. VYNE Therapeutics Inc.

Company Profile: VYNE Therapeutics Inc.
Market Cap (USD): $30.1 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

363. Angion Biomedica Corp

Company Profile: Angion Biomedica Corp
Market Cap (USD): $30.1 M (June 1, 2023)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

364. Moleculin Biotech, Inc.

Company Profile: Moleculin Biotech, Inc.
Market Cap (USD): $28.1 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

365. Vincera Pharma, Inc.

Company Profile: Vincera Pharma, Inc.
Market Cap (USD): $25.2 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

366. Spruce Biosciences, Inc.

Company Profile: Spruce Biosciences, Inc.
Market Cap (USD): $23.4 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

367. Yumanity Therapeutics, Inc.

Company Profile: Yumanity Therapeutics, Inc.
Market Cap (USD): $20.5 M (Dec. 1, 2022)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

368. Sensei Biotherapeutics, Inc.

Company Profile: Sensei Biotherapeutics, Inc.
Market Cap (USD): $19.2 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

369. NeuroBo Pharmaceuticals, Inc.

Company Profile: NeuroBo Pharmaceuticals, Inc.
Market Cap (USD): $18.8 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

370. Aprea Therapeutics, Inc.

Company Profile: Aprea Therapeutics, Inc.
Market Cap (USD): $18.8 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

371. Metacrine, Inc.

Company Profile: Metacrine, Inc.
Market Cap (USD): $18.8 M (Jan. 1, 2023)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

372. Cocrystal Pharma, Inc.

Company Profile: Cocrystal Pharma, Inc.
Market Cap (USD): $18.5 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

373. Acorda Therapeutics, Inc.

Company Profile: Acorda Therapeutics, Inc.
Market Cap (USD): $18.0 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

374. Cara Therapeutics, Inc.

Company Profile: Cara Therapeutics, Inc.
Market Cap (USD): $17.7 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

375. GlycoMimetics, Inc.

Company Profile: GlycoMimetics, Inc.
Market Cap (USD): $17.1 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

376. Lyra Therapeutics, Inc.

Company Profile: Lyra Therapeutics, Inc.
Market Cap (USD): $16.6 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

377. Acer Therapeutics Inc.

Company Profile: Acer Therapeutics Inc.
Market Cap (USD): $16.1 M (Nov. 1, 2023)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

378. Onconova Therapeutics, Inc.

Company Profile: Onconova Therapeutics, Inc.
Market Cap (USD): $15.6 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

379. BioCardia, Inc.

Company Profile: BioCardia, Inc.
Market Cap (USD): $15.3 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

380. Aytu BioScience, Inc.

Company Profile: Aytu BioScience, Inc.
Market Cap (USD): $15.2 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

381. Frequency Therapeutics, Inc.

Company Profile: Frequency Therapeutics, Inc.
Market Cap (USD): $14.3 M (July 1, 2023)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

382. Aileron Therapeutics, Inc.

Company Profile: Aileron Therapeutics, Inc.
Market Cap (USD): $14.3 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

383. Orgenesis Inc.

Company Profile: Orgenesis Inc.
Market Cap (USD): $13.9 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

384. Landos Biopharma, Inc.

Company Profile: Landos Biopharma, Inc.
Market Cap (USD): $13.7 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

385. Applied Molecular Transport Inc.

Company Profile: Applied Molecular Transport Inc.
Market Cap (USD): $11.0 M (Dec. 1, 2023)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

386. ABVC BioPharma, Inc.

Company Profile: ABVC BioPharma, Inc.
Market Cap (USD): $10.6 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

387. Virios Therapeutics, LLC

Company Profile: Virios Therapeutics, LLC
Market Cap (USD): $10.4 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

388. Cyclerion Therapeutics, Inc.

Company Profile: Cyclerion Therapeutics, Inc.
Market Cap (USD): $9.1 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

389. Vaccinex, Inc.

Company Profile: Vaccinex, Inc.
Market Cap (USD): $9.0 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

390. Aravive, Inc.

Company Profile: Aravive, Inc.
Market Cap (USD): $8.9 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

Top 1-year algo backtest: +265.99% - Try Disfold DeepFinance for FREE now!

Stay in touch